Click for best price
ImmunoCell Therapy Market Size, Share 2023
Immuno-Cell Therapy is known as a systemic treatment with minimal adverse reaction in cancer treatment. Basic concept of the therapy is to strengthen immune function of human body for elimination of any abnormal cells such as virus-infected or malignant cells from the body.
This report aims to provide a comprehensive presentation of the global market for Immuno-Cell Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Immuno-Cell Therapy. This report contains market size and forecasts of Immuno-Cell Therapy in global, including the following market information:
Global Immuno-Cell Therapy Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global top five companies in 2022 (%)
The global Immuno-Cell Therapy market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Passive Immune (NK, LAK etc) Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Immuno-Cell Therapy include MEDINET Co, Erytech, Seta Clinic Group, Takeda, SBI Holdings, Oxford BioTherapeutics, Fate Therapeutics, Gilead Sciences and Novartis, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Immuno-Cell Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Immuno-Cell Therapy Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Immuno-Cell Therapy Market Segment Percentages, by Type, 2022 (%)
Passive Immune (NK, LAK etc)
Active Immune
Global Immuno-Cell Therapy Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Immuno-Cell Therapy Market Segment Percentages, by Application, 2022 (%)
Oncology
Cardiovascular Disease (CVD)
Orthopedic
Wound Healing
Others
Global Immuno-Cell Therapy Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Immuno-Cell Therapy Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Immuno-Cell Therapy revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Immuno-Cell Therapy revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
MEDINET Co
Erytech
Seta Clinic Group
Takeda
SBI Holdings
Oxford BioTherapeutics
Fate Therapeutics
Gilead Sciences
Novartis
Osiris
Vericel Corporation
Fujifilm Cellular Dynamics
JCR Pharmaceuticals
Beike Biotechnology
Golden Meditech
Guanhao Biotech
Beroni Group
Outline of Major Chapters:
Chapter 1: Introduces the definition of Immuno-Cell Therapy, market overview.
Chapter 2: Global Immuno-Cell Therapy market size in revenue.
Chapter 3: Detailed analysis of Immuno-Cell Therapy company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Immuno-Cell Therapy in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Immuno-Cell Therapy Market, Global Outlook and Forecast 2023-2030 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
106 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Immuno-Cell Therapy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Immuno-Cell Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Immuno-Cell Therapy Overall Market Size
2.1 Global Immuno-Cell Therapy Market Size: 2022 VS 2030
2.2 Global Immuno-Cell Therapy Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Immuno-Cell Therapy Players in Global Market
3.2 Top Global Immuno-Cell Therapy Companies Ranked by Revenue
3.3 Global Immuno-Cell Therapy Revenue by Companies
3.4 Top 3 and Top 5 Immuno-Cell Therapy Companies in Global Market, by Revenue in 2022
3.5 Global Companies Immuno-Cell Therapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 Immuno-Cell Therapy Players in Global Market
3.6.1 List of Global Tier 1 Immuno-Cell Therapy Companies
3.6.2 List of Global Tier 2 and Tier 3 Immuno-Cell Therapy Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Immuno-Cell Therapy Market Size Markets, 2022 & 2030
4.1.2 Passive Immune (NK, LAK etc)
4.1.3 Active Immune
4.2 By Type - Global Immuno-Cell Therapy Revenue & Forecasts
4.2.1 By Type - Global Immuno-Cell Therapy Revenue, 2018-2023
4.2.2 By Type - Global Immuno-Cell Therapy Revenue, 2024-2030
4.2.3 By Type - Global Immuno-Cell Therapy Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Immuno-Cell Therapy Market Size, 2022 & 2030
5.1.2 Oncology
5.1.3 Cardiovascular Disease (CVD)
5.1.4 Orthopedic
5.1.5 Wound Healing
5.1.6 Others
5.2 By Application - Global Immuno-Cell Therapy Revenue & Forecasts
5.2.1 By Application - Global Immuno-Cell Therapy Revenue, 2018-2023
5.2.2 By Application - Global Immuno-Cell Therapy Revenue, 2024-2030
5.2.3 By Application - Global Immuno-Cell Therapy Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Immuno-Cell Therapy Market Size, 2022 & 2030
6.2 By Region - Global Immuno-Cell Therapy Revenue & Forecasts
6.2.1 By Region - Global Immuno-Cell Therapy Revenue, 2018-2023
6.2.2 By Region - Global Immuno-Cell Therapy Revenue, 2024-2030
6.2.3 By Region - Global Immuno-Cell Therapy Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Immuno-Cell Therapy Revenue, 2018-2030
6.3.2 US Immuno-Cell Therapy Market Size, 2018-2030
6.3.3 Canada Immuno-Cell Therapy Market Size, 2018-2030
6.3.4 Mexico Immuno-Cell Therapy Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Immuno-Cell Therapy Revenue, 2018-2030
6.4.2 Germany Immuno-Cell Therapy Market Size, 2018-2030
6.4.3 France Immuno-Cell Therapy Market Size, 2018-2030
6.4.4 U.K. Immuno-Cell Therapy Market Size, 2018-2030
6.4.5 Italy Immuno-Cell Therapy Market Size, 2018-2030
6.4.6 Russia Immuno-Cell Therapy Market Size, 2018-2030
6.4.7 Nordic Countries Immuno-Cell Therapy Market Size, 2018-2030
6.4.8 Benelux Immuno-Cell Therapy Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Immuno-Cell Therapy Revenue, 2018-2030
6.5.2 China Immuno-Cell Therapy Market Size, 2018-2030
6.5.3 Japan Immuno-Cell Therapy Market Size, 2018-2030
6.5.4 South Korea Immuno-Cell Therapy Market Size, 2018-2030
6.5.5 Southeast Asia Immuno-Cell Therapy Market Size, 2018-2030
6.5.6 India Immuno-Cell Therapy Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Immuno-Cell Therapy Revenue, 2018-2030
6.6.2 Brazil Immuno-Cell Therapy Market Size, 2018-2030
6.6.3 Argentina Immuno-Cell Therapy Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Immuno-Cell Therapy Revenue, 2018-2030
6.7.2 Turkey Immuno-Cell Therapy Market Size, 2018-2030
6.7.3 Israel Immuno-Cell Therapy Market Size, 2018-2030
6.7.4 Saudi Arabia Immuno-Cell Therapy Market Size, 2018-2030
6.7.5 UAE Immuno-Cell Therapy Market Size, 2018-2030
7 Immuno-Cell Therapy Companies Profiles
7.1 MEDINET Co
7.1.1 MEDINET Co Company Summary
7.1.2 MEDINET Co Business Overview
7.1.3 MEDINET Co Immuno-Cell Therapy Major Product Offerings
7.1.4 MEDINET Co Immuno-Cell Therapy Revenue in Global Market (2018-2023)
7.1.5 MEDINET Co Key News & Latest Developments
7.2 Erytech
7.2.1 Erytech Company Summary
7.2.2 Erytech Business Overview
7.2.3 Erytech Immuno-Cell Therapy Major Product Offerings
7.2.4 Erytech Immuno-Cell Therapy Revenue in Global Market (2018-2023)
7.2.5 Erytech Key News & Latest Developments
7.3 Seta Clinic Group
7.3.1 Seta Clinic Group Company Summary
7.3.2 Seta Clinic Group Business Overview
7.3.3 Seta Clinic Group Immuno-Cell Therapy Major Product Offerings
7.3.4 Seta Clinic Group Immuno-Cell Therapy Revenue in Global Market (2018-2023)
7.3.5 Seta Clinic Group Key News & Latest Developments
7.4 Takeda
7.4.1 Takeda Company Summary
7.4.2 Takeda Business Overview
7.4.3 Takeda Immuno-Cell Therapy Major Product Offerings
7.4.4 Takeda Immuno-Cell Therapy Revenue in Global Market (2018-2023)
7.4.5 Takeda Key News & Latest Developments
7.5 SBI Holdings
7.5.1 SBI Holdings Company Summary
7.5.2 SBI Holdings Business Overview
7.5.3 SBI Holdings Immuno-Cell Therapy Major Product Offerings
7.5.4 SBI Holdings Immuno-Cell Therapy Revenue in Global Market (2018-2023)
7.5.5 SBI Holdings Key News & Latest Developments
7.6 Oxford BioTherapeutics
7.6.1 Oxford BioTherapeutics Company Summary
7.6.2 Oxford BioTherapeutics Business Overview
7.6.3 Oxford BioTherapeutics Immuno-Cell Therapy Major Product Offerings
7.6.4 Oxford BioTherapeutics Immuno-Cell Therapy Revenue in Global Market (2018-2023)
7.6.5 Oxford BioTherapeutics Key News & Latest Developments
7.7 Fate Therapeutics
7.7.1 Fate Therapeutics Company Summary
7.7.2 Fate Therapeutics Business Overview
7.7.3 Fate Therapeutics Immuno-Cell Therapy Major Product Offerings
7.7.4 Fate Therapeutics Immuno-Cell Therapy Revenue in Global Market (2018-2023)
7.7.5 Fate Therapeutics Key News & Latest Developments
7.8 Gilead Sciences
7.8.1 Gilead Sciences Company Summary
7.8.2 Gilead Sciences Business Overview
7.8.3 Gilead Sciences Immuno-Cell Therapy Major Product Offerings
7.8.4 Gilead Sciences Immuno-Cell Therapy Revenue in Global Market (2018-2023)
7.8.5 Gilead Sciences Key News & Latest Developments
7.9 Novartis
7.9.1 Novartis Company Summary
7.9.2 Novartis Business Overview
7.9.3 Novartis Immuno-Cell Therapy Major Product Offerings
7.9.4 Novartis Immuno-Cell Therapy Revenue in Global Market (2018-2023)
7.9.5 Novartis Key News & Latest Developments
7.10 Osiris
7.10.1 Osiris Company Summary
7.10.2 Osiris Business Overview
7.10.3 Osiris Immuno-Cell Therapy Major Product Offerings
7.10.4 Osiris Immuno-Cell Therapy Revenue in Global Market (2018-2023)
7.10.5 Osiris Key News & Latest Developments
7.11 Vericel Corporation
7.11.1 Vericel Corporation Company Summary
7.11.2 Vericel Corporation Business Overview
7.11.3 Vericel Corporation Immuno-Cell Therapy Major Product Offerings
7.11.4 Vericel Corporation Immuno-Cell Therapy Revenue in Global Market (2018-2023)
7.11.5 Vericel Corporation Key News & Latest Developments
7.12 Fujifilm Cellular Dynamics
7.12.1 Fujifilm Cellular Dynamics Company Summary
7.12.2 Fujifilm Cellular Dynamics Business Overview
7.12.3 Fujifilm Cellular Dynamics Immuno-Cell Therapy Major Product Offerings
7.12.4 Fujifilm Cellular Dynamics Immuno-Cell Therapy Revenue in Global Market (2018-2023)
7.12.5 Fujifilm Cellular Dynamics Key News & Latest Developments
7.13 JCR Pharmaceuticals
7.13.1 JCR Pharmaceuticals Company Summary
7.13.2 JCR Pharmaceuticals Business Overview
7.13.3 JCR Pharmaceuticals Immuno-Cell Therapy Major Product Offerings
7.13.4 JCR Pharmaceuticals Immuno-Cell Therapy Revenue in Global Market (2018-2023)
7.13.5 JCR Pharmaceuticals Key News & Latest Developments
7.14 Beike Biotechnology
7.14.1 Beike Biotechnology Company Summary
7.14.2 Beike Biotechnology Business Overview
7.14.3 Beike Biotechnology Immuno-Cell Therapy Major Product Offerings
7.14.4 Beike Biotechnology Immuno-Cell Therapy Revenue in Global Market (2018-2023)
7.14.5 Beike Biotechnology Key News & Latest Developments
7.15 Golden Meditech
7.15.1 Golden Meditech Company Summary
7.15.2 Golden Meditech Business Overview
7.15.3 Golden Meditech Immuno-Cell Therapy Major Product Offerings
7.15.4 Golden Meditech Immuno-Cell Therapy Revenue in Global Market (2018-2023)
7.15.5 Golden Meditech Key News & Latest Developments
7.16 Guanhao Biotech
7.16.1 Guanhao Biotech Company Summary
7.16.2 Guanhao Biotech Business Overview
7.16.3 Guanhao Biotech Immuno-Cell Therapy Major Product Offerings
7.16.4 Guanhao Biotech Immuno-Cell Therapy Revenue in Global Market (2018-2023)
7.16.5 Guanhao Biotech Key News & Latest Developments
7.17 Beroni Group
7.17.1 Beroni Group Company Summary
7.17.2 Beroni Group Business Overview
7.17.3 Beroni Group Immuno-Cell Therapy Major Product Offerings
7.17.4 Beroni Group Immuno-Cell Therapy Revenue in Global Market (2018-2023)
7.17.5 Beroni Group Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Immuno-Cell Therapy Market Opportunities & Trends in Global Market
Table 2. Immuno-Cell Therapy Market Drivers in Global Market
Table 3. Immuno-Cell Therapy Market Restraints in Global Market
Table 4. Key Players of Immuno-Cell Therapy in Global Market
Table 5. Top Immuno-Cell Therapy Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Immuno-Cell Therapy Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Immuno-Cell Therapy Revenue Share by Companies, 2018-2023
Table 8. Global Companies Immuno-Cell Therapy Product Type
Table 9. List of Global Tier 1 Immuno-Cell Therapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Immuno-Cell Therapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Immuno-Cell Therapy Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Immuno-Cell Therapy Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Immuno-Cell Therapy Revenue in Global (US$, Mn), 2024-2030
Table 14. By Application ? Global Immuno-Cell Therapy Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Immuno-Cell Therapy Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Immuno-Cell Therapy Revenue in Global (US$, Mn), 2024-2030
Table 17. By Region ? Global Immuno-Cell Therapy Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Immuno-Cell Therapy Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Immuno-Cell Therapy Revenue (US$, Mn), 2024-2030
Table 20. By Country - North America Immuno-Cell Therapy Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Immuno-Cell Therapy Revenue, (US$, Mn), 2024-2030
Table 22. By Country - Europe Immuno-Cell Therapy Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Immuno-Cell Therapy Revenue, (US$, Mn), 2024-2030
Table 24. By Region - Asia Immuno-Cell Therapy Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Immuno-Cell Therapy Revenue, (US$, Mn), 2024-2030
Table 26. By Country - South America Immuno-Cell Therapy Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Immuno-Cell Therapy Revenue, (US$, Mn), 2024-2030
Table 28. By Country - Middle East & Africa Immuno-Cell Therapy Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Immuno-Cell Therapy Revenue, (US$, Mn), 2024-2030
Table 30. MEDINET Co Company Summary
Table 31. MEDINET Co Immuno-Cell Therapy Product Offerings
Table 32. MEDINET Co Immuno-Cell Therapy Revenue (US$, Mn) & (2018-2023)
Table 33. MEDINET Co Key News & Latest Developments
Table 34. Erytech Company Summary
Table 35. Erytech Immuno-Cell Therapy Product Offerings
Table 36. Erytech Immuno-Cell Therapy Revenue (US$, Mn) & (2018-2023)
Table 37. Erytech Key News & Latest Developments
Table 38. Seta Clinic Group Company Summary
Table 39. Seta Clinic Group Immuno-Cell Therapy Product Offerings
Table 40. Seta Clinic Group Immuno-Cell Therapy Revenue (US$, Mn) & (2018-2023)
Table 41. Seta Clinic Group Key News & Latest Developments
Table 42. Takeda Company Summary
Table 43. Takeda Immuno-Cell Therapy Product Offerings
Table 44. Takeda Immuno-Cell Therapy Revenue (US$, Mn) & (2018-2023)
Table 45. Takeda Key News & Latest Developments
Table 46. SBI Holdings Company Summary
Table 47. SBI Holdings Immuno-Cell Therapy Product Offerings
Table 48. SBI Holdings Immuno-Cell Therapy Revenue (US$, Mn) & (2018-2023)
Table 49. SBI Holdings Key News & Latest Developments
Table 50. Oxford BioTherapeutics Company Summary
Table 51. Oxford BioTherapeutics Immuno-Cell Therapy Product Offerings
Table 52. Oxford BioTherapeutics Immuno-Cell Therapy Revenue (US$, Mn) & (2018-2023)
Table 53. Oxford BioTherapeutics Key News & Latest Developments
Table 54. Fate Therapeutics Company Summary
Table 55. Fate Therapeutics Immuno-Cell Therapy Product Offerings
Table 56. Fate Therapeutics Immuno-Cell Therapy Revenue (US$, Mn) & (2018-2023)
Table 57. Fate Therapeutics Key News & Latest Developments
Table 58. Gilead Sciences Company Summary
Table 59. Gilead Sciences Immuno-Cell Therapy Product Offerings
Table 60. Gilead Sciences Immuno-Cell Therapy Revenue (US$, Mn) & (2018-2023)
Table 61. Gilead Sciences Key News & Latest Developments
Table 62. Novartis Company Summary
Table 63. Novartis Immuno-Cell Therapy Product Offerings
Table 64. Novartis Immuno-Cell Therapy Revenue (US$, Mn) & (2018-2023)
Table 65. Novartis Key News & Latest Developments
Table 66. Osiris Company Summary
Table 67. Osiris Immuno-Cell Therapy Product Offerings
Table 68. Osiris Immuno-Cell Therapy Revenue (US$, Mn) & (2018-2023)
Table 69. Osiris Key News & Latest Developments
Table 70. Vericel Corporation Company Summary
Table 71. Vericel Corporation Immuno-Cell Therapy Product Offerings
Table 72. Vericel Corporation Immuno-Cell Therapy Revenue (US$, Mn) & (2018-2023)
Table 73. Vericel Corporation Key News & Latest Developments
Table 74. Fujifilm Cellular Dynamics Company Summary
Table 75. Fujifilm Cellular Dynamics Immuno-Cell Therapy Product Offerings
Table 76. Fujifilm Cellular Dynamics Immuno-Cell Therapy Revenue (US$, Mn) & (2018-2023)
Table 77. Fujifilm Cellular Dynamics Key News & Latest Developments
Table 78. JCR Pharmaceuticals Company Summary
Table 79. JCR Pharmaceuticals Immuno-Cell Therapy Product Offerings
Table 80. JCR Pharmaceuticals Immuno-Cell Therapy Revenue (US$, Mn) & (2018-2023)
Table 81. JCR Pharmaceuticals Key News & Latest Developments
Table 82. Beike Biotechnology Company Summary
Table 83. Beike Biotechnology Immuno-Cell Therapy Product Offerings
Table 84. Beike Biotechnology Immuno-Cell Therapy Revenue (US$, Mn) & (2018-2023)
Table 85. Beike Biotechnology Key News & Latest Developments
Table 86. Golden Meditech Company Summary
Table 87. Golden Meditech Immuno-Cell Therapy Product Offerings
Table 88. Golden Meditech Immuno-Cell Therapy Revenue (US$, Mn) & (2018-2023)
Table 89. Golden Meditech Key News & Latest Developments
Table 90. Guanhao Biotech Company Summary
Table 91. Guanhao Biotech Immuno-Cell Therapy Product Offerings
Table 92. Guanhao Biotech Immuno-Cell Therapy Revenue (US$, Mn) & (2018-2023)
Table 93. Guanhao Biotech Key News & Latest Developments
Table 94. Beroni Group Company Summary
Table 95. Beroni Group Immuno-Cell Therapy Product Offerings
Table 96. Beroni Group Immuno-Cell Therapy Revenue (US$, Mn) & (2018-2023)
Table 97. Beroni Group Key News & Latest Developments
List of Figures
Figure 1. Immuno-Cell Therapy Segment by Type in 2022
Figure 2. Immuno-Cell Therapy Segment by Application in 2022
Figure 3. Global Immuno-Cell Therapy Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Immuno-Cell Therapy Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Immuno-Cell Therapy Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Immuno-Cell Therapy Revenue in 2022
Figure 8. By Type - Global Immuno-Cell Therapy Revenue Market Share, 2018-2030
Figure 9. By Application - Global Immuno-Cell Therapy Revenue Market Share, 2018-2030
Figure 10. By Type - Global Immuno-Cell Therapy Revenue, (US$, Mn), 2022 & 2030
Figure 11. By Type - Global Immuno-Cell Therapy Revenue Market Share, 2018-2030
Figure 12. By Application - Global Immuno-Cell Therapy Revenue, (US$, Mn), 2022 & 2030
Figure 13. By Application - Global Immuno-Cell Therapy Revenue Market Share, 2018-2030
Figure 14. By Region - Global Immuno-Cell Therapy Revenue Market Share, 2018-2030
Figure 15. By Country - North America Immuno-Cell Therapy Revenue Market Share, 2018-2030
Figure 16. US Immuno-Cell Therapy Revenue, (US$, Mn), 2018-2030
Figure 17. Canada Immuno-Cell Therapy Revenue, (US$, Mn), 2018-2030
Figure 18. Mexico Immuno-Cell Therapy Revenue, (US$, Mn), 2018-2030
Figure 19. By Country - Europe Immuno-Cell Therapy Revenue Market Share, 2018-2030
Figure 20. Germany Immuno-Cell Therapy Revenue, (US$, Mn), 2018-2030
Figure 21. France Immuno-Cell Therapy Revenue, (US$, Mn), 2018-2030
Figure 22. U.K. Immuno-Cell Therapy Revenue, (US$, Mn), 2018-2030
Figure 23. Italy Immuno-Cell Therapy Revenue, (US$, Mn), 2018-2030
Figure 24. Russia Immuno-Cell Therapy Revenue, (US$, Mn), 2018-2030
Figure 25. Nordic Countries Immuno-Cell Therapy Revenue, (US$, Mn), 2018-2030
Figure 26. Benelux Immuno-Cell Therapy Revenue, (US$, Mn), 2018-2030
Figure 27. By Region - Asia Immuno-Cell Therapy Revenue Market Share, 2018-2030
Figure 28. China Immuno-Cell Therapy Revenue, (US$, Mn), 2018-2030
Figure 29. Japan Immuno-Cell Therapy Revenue, (US$, Mn), 2018-2030
Figure 30. South Korea Immuno-Cell Therapy Revenue, (US$, Mn), 2018-2030
Figure 31. Southeast Asia Immuno-Cell Therapy Revenue, (US$, Mn), 2018-2030
Figure 32. India Immuno-Cell Therapy Revenue, (US$, Mn), 2018-2030
Figure 33. By Country - South America Immuno-Cell Therapy Revenue Market Share, 2018-2030
Figure 34. Brazil Immuno-Cell Therapy Revenue, (US$, Mn), 2018-2030
Figure 35. Argentina Immuno-Cell Therapy Revenue, (US$, Mn), 2018-2030
Figure 36. By Country - Middle East & Africa Immuno-Cell Therapy Revenue Market Share, 2018-2030
Figure 37. Turkey Immuno-Cell Therapy Revenue, (US$, Mn), 2018-2030
Figure 38. Israel Immuno-Cell Therapy Revenue, (US$, Mn), 2018-2030
Figure 39. Saudi Arabia Immuno-Cell Therapy Revenue, (US$, Mn), 2018-2030
Figure 40. UAE Immuno-Cell Therapy Revenue, (US$, Mn), 2018-2030
Figure 41. MEDINET Co Immuno-Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Erytech Immuno-Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Seta Clinic Group Immuno-Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Takeda Immuno-Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. SBI Holdings Immuno-Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Oxford BioTherapeutics Immuno-Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Fate Therapeutics Immuno-Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Gilead Sciences Immuno-Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Novartis Immuno-Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Osiris Immuno-Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Vericel Corporation Immuno-Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Fujifilm Cellular Dynamics Immuno-Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. JCR Pharmaceuticals Immuno-Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. Beike Biotechnology Immuno-Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 55. Golden Meditech Immuno-Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 56. Guanhao Biotech Immuno-Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 57. Beroni Group Immuno-Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
